对前列腺癌患者在放射治疗期间使用交互式应用程序支持的评估 - 一个双臂随机对照试验
Nazmije Kelmendi1, Marie-Therése Crafoord2, Kay Sundberg3
1Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Alfred Nobels Allé 23, 141 52, Stockholm, Sweden; Academic Primary Health Care Center, Region Stockholm, Box 45436, 104 31, Stockholm, Sweden.
概括
这项研究评估了前列腺癌患者接受放射治疗的数字应用程序干预. 该应用程序提高了症状意识,并可能减少肠道症状,与标准护理相比提供了更好的支持.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 患者支持 患者支持
背景情况:
- 前列腺癌的放射治疗往往导致显著的症状负担.
- 在治疗期间,有效的症状管理和患者支持至关重要.
- 数字工具为改善患者监测和自我管理提供了潜力.
研究的目的:
- 评估一个数字干预,结合基于应用程序的症状监测,自我管理和护士在放射治疗期间为前列腺癌患者提供支持.
- 评估干预对与健康有关的生活质量和症状负担的影响.
主要方法:
- 一项随机对照试验,包括150名前列腺癌患者 (75名干预,75名控制).
- 干预组使用了症状监测应用程序;对照组接受了标准护理.
- 定量数据 (验证的问卷) 和定性访谈是在基线,治疗后3周和3个月收集的.
主要成果:
- 干预组报告说从基线到3周便秘增加,而对照组显示便秘减少 (P=0.01).
- 然而,干预组在此期间与对照组相比,整体上经历了较少的肠道症状 (P=0.01).
- 定性数据显示,干预组的症状意识,安全性和支持性增强,与对照组在寻求帮助方面的不安全性形成鲜明对比.
结论:
- 数字干预在减少肠道症状和改善前列腺癌患者接受放射治疗的症状意识方面显示出有希望.
- 需要进一步的研究,以确定数字工具在支持前列腺癌放射治疗期间的患者的有效性.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K